DACLATASVIR 60 mg + SOFOSBUVIR 400 mg (Sovihep D) x 28 Tablets

Uses of Daclatasvir 60 mg + Sofosbuvir 400 mg

• Treats chronic hepatitis C virus (HCV) infection
• May be used for multiple HCV genotypes as prescribed
• Helps reduce the hepatitis C viral load
• Helps prevent further liver damage
• Supports long-term viral clearance

Benefits

• Provides high cure rates for hepatitis C in suitable patients
• Helps reduce the risk of liver cirrhosis
• Supports improved liver function
• Lowers the risk of liver-related complications
• Provides convenient once-daily oral treatment

How Does Daclatasvir 60 mg + Sofosbuvir 400 mg Work?

Daclatasvir and sofosbuvir are direct-acting antiviral medicines that target different stages of the hepatitis C virus life cycle. Daclatasvir blocks the NS5A protein, while sofosbuvir inhibits the NS5B RNA polymerase enzyme. Together, they prevent the virus from replicating and help clear the infection from the body.

Side Effects

• Headache
• Fatigue
• Nausea
• Diarrhoea
• Insomnia
• Dizziness
• Weakness
• Irritability
• Anaemia when used with certain medicines
• Elevated liver enzyme levels

Precautions

• Take the medicine exactly as prescribed by your doctor.
• Complete the full prescribed course of treatment.
• Inform your doctor if you have liver disease or a current or previous hepatitis B infection.
• Tell your healthcare provider about all medicines and supplements you are taking to help prevent drug interactions.
• Attend regular liver function tests and viral-load monitoring appointments.
• Avoid alcohol during treatment, as it may increase liver damage.
• Do not stop treatment without medical advice.